AVERNA, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 22.273
EU - Europa 7.951
AS - Asia 3.074
AF - Africa 92
SA - Sud America 56
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 7
Totale 33.473
Nazione #
US - Stati Uniti d'America 22.192
IT - Italia 2.731
CN - Cina 1.643
FI - Finlandia 1.339
UA - Ucraina 1.175
SG - Singapore 1.022
IE - Irlanda 653
DE - Germania 561
GB - Regno Unito 466
RU - Federazione Russa 217
SE - Svezia 209
FR - Francia 177
KR - Corea 110
BE - Belgio 88
TR - Turchia 78
CI - Costa d'Avorio 77
RO - Romania 70
IN - India 64
NL - Olanda 62
CA - Canada 48
PL - Polonia 38
CH - Svizzera 37
HK - Hong Kong 34
IR - Iran 31
MX - Messico 31
BR - Brasile 29
JP - Giappone 24
AT - Austria 21
ES - Italia 18
GR - Grecia 18
AU - Australia 16
BG - Bulgaria 13
CZ - Repubblica Ceca 11
CL - Cile 9
MY - Malesia 9
PT - Portogallo 9
UZ - Uzbekistan 8
VN - Vietnam 7
EU - Europa 6
HR - Croazia 6
DK - Danimarca 5
IL - Israele 5
PE - Perù 5
PK - Pakistan 5
CO - Colombia 4
EC - Ecuador 4
EG - Egitto 4
HU - Ungheria 4
IQ - Iraq 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
SI - Slovenia 4
BO - Bolivia 3
CY - Cipro 3
MD - Moldavia 3
MK - Macedonia 3
NG - Nigeria 3
PH - Filippine 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TW - Taiwan 3
YE - Yemen 3
BA - Bosnia-Erzegovina 2
BJ - Benin 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
PA - Panama 2
RS - Serbia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
AR - Argentina 1
BD - Bangladesh 1
ID - Indonesia 1
KE - Kenya 1
ME - Montenegro 1
MN - Mongolia 1
OM - Oman 1
PY - Paraguay 1
SC - Seychelles 1
TN - Tunisia 1
Totale 33.473
Città #
Fairfield 3.655
Ashburn 2.151
Woodbridge 1.898
Houston 1.603
Wilmington 1.553
Chandler 1.536
Seattle 1.523
Cambridge 1.171
Ann Arbor 849
Singapore 812
Dublin 650
Jacksonville 639
Medford 545
Palermo 426
Nanjing 372
Altamura 360
Princeton 346
San Diego 256
Lawrence 250
Des Moines 240
Dearborn 208
Boardman 194
New York 189
Tulsa 177
Beijing 151
Milan 138
Shenyang 133
Santa Clara 120
Nanchang 107
London 93
Hebei 91
Jinan 90
Ludwigshafen am Rhein 87
Changsha 86
Seongnam 86
Brussels 80
Tianjin 78
Abidjan 77
Rome 76
Izmir 71
Jiaxing 63
Saint Petersburg 57
Helsinki 52
Ningbo 48
Venice 44
Düsseldorf 43
Munich 42
Zhengzhou 42
Phoenix 40
Guangzhou 38
San Mateo 38
San Paolo di Civitate 38
Verona 38
Bremen 36
Los Angeles 35
Falls Church 33
Norwalk 32
Redwood City 30
Kumar 28
Hangzhou 27
Auburn Hills 26
Kunming 26
Haikou 25
Lanzhou 25
Taiyuan 25
Columbus 24
Orange 24
Taizhou 23
Redmond 22
Shanghai 22
Ottawa 21
Tehran 21
Washington 21
Naples 19
Bologna 18
Moscow 18
Catania 16
Chicago 16
Groningen 15
Hefei 15
Hong Kong 15
Kilburn 15
Napoli 15
Florence 14
Pune 13
Kraków 12
Minamiyukigaya 11
Paris 11
Sofia 11
Dallas 10
Favara 10
Padova 10
Reggio Emilia 10
San Francisco 10
Turin 10
Detroit 9
Forest City 9
Frankfurt am Main 9
Indiana 9
Kiev 9
Totale 24.615
Nome #
Le Dislipidemie Genetiche. Il Progetto LIPIGEN 281
Multiple food hypersensitivity as a cause of refractory chronic constipation in adults 276
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events 235
Resting energy expenditure and substrate oxidation in malnourished patients with type 1 glycogenosis 204
CEREBROTENDINOUS XANTHOMATOSIS: A SICILIAN FAMILY HARBOURING THE R362C MUTATION IN THE STEROL 27-HYDROXYLASE GENE 195
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 194
The production of 85 kDa N-terminal fragment of apolipoprotein B in mutant HepG2 cells generated by targeted modification of apoB gene occurs by ALLN-inhibitable protease cleavage during translocation. 181
A novel mutation of the extracellular matrix protein 1 gene (ECM1) in a patient with lipoid proteinosis (Urbach-Wiethe disease) from Sicily 167
LINEE GUIDA CLINICHE PER LA PREVENZIONE DELLA CARDIOPATIA ISCHEMICA NELLA IPERCOLESTEROLEMIA FAMILIARE Una patologia sotto-diagnosticata e sotto-trattata 165
Heparin induces an accumulation of atherogenic lipoproteins during hemodialysis in normolipidemic end-stage renal disease patients. 164
Baseline metabolic disturbances and the twenty-five years risk of incident cancer in a Mediterranean population 163
Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred 163
Six novel mutations of the LDL receptor gene in FH kindred of Sicilian and Paraguayan descent 161
Interleukin 6 plasma levels predict with high sensitivity and specificity coronary stenosis detected by coronary angiography 161
Lipoprotein-associated phospholipase A2 activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia 161
Association between HFE mutations and acute myocardial infarction: a study in patients from Northern and Southern Italy 159
C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients. 158
The ANP Genetic Variant RS5068 is Associated With a Favorable Cardiometabolic Phenotype in a Mediterranean Population 157
Novel mutations of CETP gene in Italian subjects with hyeralphalipoproteinemia 157
A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol. 157
A Novel Mutation of the DHCR7 Gene in a Sicilian Compound Heterozygote with Smith-Lemli-Opitz Syndrome 156
FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease 156
GASTROINTESTINAL SYMPTOMS IN INFANCY: A POPULATION-BASED PROSPECTIVE STUDY 155
A NOVEL NONSENSE MUTATION IN THE CETP GENE IN ITALIAN HYPERALPHALIPOPROTEINEMIC SUBJECTS 154
Chronic constipation and food intolerance: a model of proctitis causing constipation 153
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the Low-HDL Phenotype 153
Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial 153
BETA-2-GLYCOPROTEIN I IS GROWTH REGULATED AND PLAYS A ROLE AS SURVIVAL FACTOR FOR HEPATOCYTES 152
Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score” 152
Bovine seminal ribonuclease is cytotoxic for both malignant and normal telomerase-positive cells 151
Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia. 151
Clinical, pathologic, and genetic features of massive soft tissue neurofibromas in a Sicilian patient 151
REDUCTION OF CHOLESTEROL WITH NUTRACEUTICAL: RESULTS OF A DOUBLE BLIND STUDY 151
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 151
PCSK9-D374Y mediated LDL-R degradation can be functionally inhibited by EGF-A and truncated EGF-A peptides: An in vitro study 151
A novel component of the metabolic syndrome : The oxidative stress 150
Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity. 149
TERAPIA CON STATINE IN PAZIENTI SICILIANI AFFETTI DA IPERLIPIDEMIA FAMILIARE COMBINATA 149
Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease 149
The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: Results of a 15 years follow-up in a Mediterranean population. 149
Role of Nutraceuticals in Hypolipidemic Therapy 148
Behavior of the total antioxidant status in a group of subjects with metabolic syndrome. 147
Association of estrogen receptor alpha gene with Alzheimer's disease: a case-control study 145
Hypertension and diabetes mellitus are associated with cardiovascular events in the elderly without cardiovascular disease. Results of a 15-year follow-up in a Mediterranean population 145
IL GENE PCSK9: UN NUOVO GENE IMPLICATO NEL CONTROLLO DELLA COLESTEROLEMIA 144
Analysis of sterols by high-performance liquid chromatography/mass spectrometry combined with chemometrics 143
A NOVEL APOB MUTATION IDENTIFIED BY EXOME SEQUENCING COSEGREGATES WITH STEATOSIS, LIVER CANCER AND HYPOCHOLESTEROLEMIA 143
Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children 143
Anti-actin antibodies in celiac disease: correlation with intestinal mucosa damage and comparison of ELISA with the immunofluorescence assay. 142
Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemia. 142
Efficacy and Safety of Ezetimibe Added to Atorvastatin Versus Atorvastatin Uptitration or Switching to Rosuvastatin in Patients With Primary Hypercholesterolemia 141
Gene expression in mouse spermatogenesis during ontogenesis. 140
INTERLEUKIN 6 PLASMA LEVELS PREDICT WITH HIGH SENSITIVITY AND SPECIFICITY CORONARY STENOSIS DETECTED BY CORONARY ANGIOGRAPHY 140
No association between the cystatin C gene polymorphism and Alzheimer's disease: a case-control study in an Italian population. 140
ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: Diagnostic-therapeutic pathway in Italy 140
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society 140
PREVALENCE OF ANGPTL3 AND APOB GENE MUTATIONS IN SUBJECTS WITH COMBINED HYPOLIPIDEMIA 139
Apolipoprotein AI and HDL are reduced in stable cirrhotic patients with adrenal insufficiency: A possible role in glucocorticoid deficiency 139
Obesity and the metabolic syndrome in a student cohort from Southern Italy 138
LIPASE MATURATION FACTOR 1 IS REQUIRED FOR ENDOTHELIAL LIPASE ACTIVITY 138
RUOLO DEL POLIMORFISMO ILE148MET DEL GENE PNPLA3 NELLA STEATOSI ASSOCIATA ALLA IPOBETALIPOPROTEINEMIA FAMILIARE 138
Myristic acid is associated to low plasma HDL cholesterol levels in a Mediterranean population and increases HDL catabolism by enhancing HDL particles trapping to cell surface proteoglycans in a liver hepatoma cell model 138
Albumin versus solvent/detergent-treated pooled plasma as replacement fluid for long-term plasma exchange therapy in a patient with primary hypertriglyceridemia and recurrent hyperlipidemic pancreatitis 138
PREVALENCE OF APOB VARIANTS IN A SAMPLE OF SUBJECTS WITH HYPOCHOLESTEROLEMIA 137
Genetics of familial hypobetalipoproteinemia 137
Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing 137
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 137
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke 136
Evaluation of nitric oxide metabolites in a group of subjects with metabolic syndrome. 136
Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity. 136
CLINICAL CHARACTERISTICS AND PLASMA LIPIDS IN SUBJECTS WITH FAMILIAL COMBINED HYPOLIPIDEMIA: A POOLED ANALYSIS 136
Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia 135
Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia 135
Prediction of incident type 2 diabetes mellitus based on a twenty-year follow-up of the Ventimiglia heart study 135
Plasma levels of lipoproteins and apolipoproteins in congenital hypothyroidism: effects of L-thyroxine substitution therapy 135
Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia 134
Familial combined hypolipidemia due to mutations in the ANGPTL3 gene 134
A NOVEL COMPOUND HETEROZYGOUS MUTATION OF THE LIPOPROTEIN LIPASE GENE IN A NEWBORN WITH CHYLOMICRONEMIA 133
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 133
CLINICAL AND MOLECULAR CHARACTERIZATION OF HYPERCHOLESTEROLEMIC SICILIAN FAMILIES AND DESCRIPTION OF 3 NOVEL MUTATIONS IN THE LDLR GENE 132
Molecular diagnosis of hypobetalipoproteinemia: An ENID review 132
Ezetimibe/Simvastatin 10/20 mg versus Rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency. 132
Modification of the lipidic and coagulative pattern in postmenopause women: effect of hormone replacement therapy. 132
Determinants of enhanced thromboxane biosynthesis in renal transplantation 132
Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients 131
ENHANCED LIPID PEROXIDATION AND PLATELET ACTIVATION AS POTENTIAL CONTRIBUTORS TO INCREASED CARDIOVASCULAR RISK IN THE LOW-HDL PHENOTYPE. 131
Genotypic and phenotypic characterization of patients with autosomal dominant hypercholesterolemia in sicily 130
Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study. 129
Variable phenotypic expression of chylomicron retention disease in a kindred carrying a mutation of the Sara2 gene 129
Prothrombotic gene variants as risk factors of acute myocardial infarction in young women. 129
Lipid and apoprotein composition of HDL in partial or complete CETP deficiency 128
LE IPERCOLESTEROLEMIE PRIMITIVE 127
Decreased plasma soluble RAGE in patients with hypercholesterolemia: Effects of statins 126
A novel putative interactor for the low density lipoprotein receptor cytoplasmic domain 126
Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy 126
Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene. 126
Nutritional characteristics of a rural Southern Italy population: the Ventimiglia di Sicilia Project 125
Prevalence of overweight and obesity in a rural southern Italy population and relationships with total and cardiovascular mortality: The Ventimiglia di Sicilia project 124
Treating homozygous familial hypercholesterolemia in a real-world setting: Experiences with lomitapide 124
Long-term efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in patients with homozygous familial hypercholesterolemia 124
Totale 14.807
Categoria #
all - tutte 136.089
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.089


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.549 0 0 0 0 0 1.241 1.056 686 1.032 452 733 349
2020/20214.677 242 490 280 437 361 301 517 333 414 430 411 461
2021/20223.914 147 837 146 125 102 152 169 229 554 481 235 737
2022/20234.702 504 941 113 487 552 718 203 325 504 58 190 107
2023/20242.318 106 340 165 254 165 515 241 118 29 72 60 253
2024/20251.773 151 325 405 469 230 193 0 0 0 0 0 0
Totale 35.123